登录 查看组织和合同定价。
关于此项目
经验公式(希尔记法):
C42H80NO4Cl
化学文摘社编号:
分子量:
698.54
MDL number:
UNSPSC Code:
12352211
NACRES:
NA.25
跳至
产品名称
18:1 TAP (DOTAP), Avanti Research™ - A Croda Brand
SMILES string
[H]C(C[N+](C)(C)C)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Cl-]
InChI
1S/C42H80NO4.ClH/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-41(44)46-39-40(38-43(3,4)5)47-42(45)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2;/h20-23,40H,6-19,24-39H2,1-5H3;1H/q+1;/p-1/b22-20-,23-21-;
InChI key
KSXTUUUQYQYKCR-LQDDAWAPSA-M
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 1 g ((890890P-1G))
pkg of 2 × 100 mg ((890890P-200MG))
pkg of 5 × 100 mg ((890890P-100MG))
pkg of 1 × 25 mg ((890890P-25MG))
manufacturer/tradename
Avanti Research™ - A Croda Brand
application(s)
advanced drug delivery
lipid type
transfection
cationic lipids
shipped in
dry ice
storage temp.
−20°C
Biochem/physiol Actions
Packaging
5 mL透明玻璃密封安瓿瓶(890890P-200mg)
5 mL透明玻璃密封安瓿瓶(890890P-25mg)
5 mL透明玻璃密封安瓿瓶(890890P-500mg)
60 mL琥珀色宽口螺帽玻璃瓶(890890P-1g)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Related product
产品编号
说明
价格
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Analysis of cationic liposomes by reversed-phase HPLC with evaporative light-scattering detection
Zhong Z, et al.
Journal of Pharmaceutical and Biomedical Analysis, 51(4), 947-951 (2010)
DOTAP (and other cationic lipids): chemistry, biophysics, and transfection
Simberg D, et al.
Critical Reviews in Therapeutic Drug Carrier Systems, 21(4) (2004)
Efficient siRNA delivery by the cationic liposome DOTAP in human hematopoietic stem cells differentiating into dendritic cells
Martino S, et al.
BioMed Research International, 2009 (2009)
Cationic liposomes induce cytotoxicity in HepG2 via regulation of lipid metabolism based on whole-transcriptome sequencing analysis
Li Y, et al.
BMC Pharmacology & Toxicology, 19(1), 43-43 (2018)
Elias J Sayour et al.
Nano letters, 18(10), 6195-6206 (2018-09-28)
Translation of nanoparticles (NPs) into human clinical trials for patients with refractory cancers has lagged due to unknown biologic reactivities of novel NP designs. To overcome these limitations, simple well-characterized mRNA lipid-NPs have been developed as cancer immunotherapeutic vaccines. While
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持